USANA Health Sciences (USNA) Tops Q3 EPS by 27c; Trims Outlook

October 25, 2016 4:17 PM EDT
Get Alerts USNA Hot Sheet
Trade USNA Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $2.40, $0.27 better than the analyst estimate of $2.13. Revenue for the quarter came in at $254.2 million versus the consensus estimate of $263.37 million.

GUIDANCE:

USANA Health Sciences sees FY2016 EPS of $7.90-$8.10, versus prior guidance of $7.90-$8.20 and the consensus of $8.10. USANA Health Sciences sees FY2016 revenue of $1.00-1.01 billion, versus the consensus of $1.03 billion.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance, Hot Guidance

Related Entities

Earnings

Add Your Comment